About the Company
We do not have any company description for Aclaris Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ACRS News
Aclaris Therapeutics Inc ACRS
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Favourable Signals For Aclaris Therapeutics: Numerous Insiders Acquired Stock
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying ...
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer
Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision ...
Aclaris: Q4 Earnings Snapshot
WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Tuesday reported a loss of $1.5 million in its fourth quarter. The Wayne, Pennsylvania-based company said it had a loss ...
Aclaris Therapeutics Inc ACRS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Aclaris Therapeutics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Aclaris Therapeutics Inc
Analysts say investors should buy these undervalued stocks.
Aclaris Therapeutics Inc (ACRS)
View the ACRS option chain and compare options of Aclaris Therapeutics Inc stock. Analyze the various options available, including call options (the right to buy) and put options (the right to ...
Loading the latest forecasts...